EndocrineICD-10: E28.2Affects 6–12% of reproductive-age women in the US (about 5 million)

Polycystic Ovary Syndrome

Also known as: PCOS, Polycystic Ovarian Syndrome, Stein-Leventhal Syndrome

Polycystic ovary syndrome (PCOS) is a common hormonal disorder affecting women of reproductive age, characterized by irregular menstrual periods, excess androgen (male hormone) levels, and polycystic ovaries on ultrasound. It is the leading cause of female infertility and is associated with insulin resistance, metabolic syndrome, type 2 diabetes, and cardiovascular risk. Early diagnosis and management can prevent long-term complications.

Last updated October 31, 2026

Understanding Polycystic Ovary Syndrome

Polycystic ovary syndrome is not really an ovary disease, despite the name. It is a whole-body hormonal and metabolic condition in which the ovaries make too much androgen (testosterone and related hormones) and often fail to release an egg each month. The "cysts" on ultrasound are not true cysts at all but a crowd of small, stalled follicles that never matured. Because the diagnosis only needs two of three features, two women with PCOS can look very different: one may have regular periods but acne and excess hair, another may have no periods and no visible hirsutism. Roughly 70 percent of women who have it remain undiagnosed, and many are told for years that their symptoms are simply weight or stress.

Two engines drive PCOS, and they feed each other. The first is insulin resistance, which affects 65 to 95 percent of women with the condition regardless of weight: muscle and liver cells respond poorly to insulin, so the pancreas pumps out more. High insulin tells the ovaries to make more testosterone and tells the liver to make less sex hormone-binding globulin, so more of that testosterone circulates free. The second engine is a fast-pulsing luteinizing hormone (LH) signal from the pituitary that further stimulates androgen production and disrupts the orderly growth of one dominant follicle. Add low-grade inflammation and, in many women, excess abdominal fat that worsens insulin resistance, and you have a loop that sustains itself.

PCOS is lifelong, but what it looks like changes with age. In the teens and twenties the visible problems are periods, skin and hair; in the thirties fertility; and from midlife onward the metabolic consequences, including a roughly four-fold higher risk of type 2 diabetes and higher rates of fatty liver, sleep apnea and endometrial cancer when periods are very infrequent. Conventional care is organised around whichever problem matters most to you. The 2023 international guideline keeps the combined oral contraceptive pill as first-line for irregular cycles and androgen symptoms: it lowers free testosterone, protects the uterine lining and reliably regulates bleeding, though it does not treat insulin resistance. Metformin is recommended for metabolic features, especially with a BMI above 25, and improves cycles in about half of users; its main drawbacks are gut side effects and lower vitamin B12. Spironolactone adds anti-androgen effect for hair and acne, and letrozole is now first-line for ovulation induction.

Natural approaches sit closer to the centre of PCOS care than for most conditions, because the guideline itself names lifestyle change as the foundation and because inositol is one of the few supplements with enough randomised data to be discussed in a formal guideline. The honest summary: myo-inositol has the strongest supplement evidence and performs similarly to metformin on insulin and ovulation in several meta-analyses, though the 2023 guideline still grades the certainty as low. Berberine, N-acetylcysteine and omega-3 each have a handful of small randomised trials showing metabolic or ovulatory benefit. Vitamin D corrects a deficiency that is extremely common in PCOS but does not fix the syndrome. Chromium, cinnamon and magnesium are earlier-stage. None of these replace the pill for cycle regulation or letrozole for fertility; they are best used as metabolic adjuncts, or alone in mild cases where someone cannot or does not want to take medication.

The thing most people get wrong is treating PCOS as a weight problem that willpower should fix. Insulin resistance and high androgens actively promote fat storage and hunger, which is why standard calorie advice feels like pushing uphill. Lean women with PCOS have the same underlying insulin signalling problem, just less visible. The useful reframe is that modest, sustainable change moves the needle: a 5 percent weight loss, or regular resistance training with no weight loss at all, measurably improves insulin sensitivity, ovulation and androgen levels. Progress is best tracked by cycle length and insulin markers, not the scale.

At a Glance

Common symptoms
Irregular, infrequent, or absent menstrual periods, Excess hair growth on the face, chest, and back (hirsutism), Acne and oily skin
Main treatments
Lifestyle modifications (weight loss of 5–10% significantly improves symptoms), Combined oral contraceptive pills for cycle regulation and androgen reduction, Metformin for insulin resistance
Category
Endocrine · Affects 6–12% of reproductive-age women in the US (about 5 million)
See a doctor if
Irregular or absent menstrual periods

Symptoms

Irregular, infrequent, or absent menstrual periods
Excess hair growth on the face, chest, and back (hirsutism)
Acne and oily skin
Thinning hair or male-pattern baldness
Weight gain, especially around the abdomen
Darkened skin patches (acanthosis nigricans)
Difficulty getting pregnant (infertility)
Mood changes including anxiety and depression

Causes

  • Hormonal imbalance with elevated androgens
  • Insulin resistance and compensatory hyperinsulinemia
  • Genetic predisposition (multiple genes involved)
  • Low-grade chronic inflammation

Risk Factors

  • Family history of PCOS
  • Obesity or overweight
  • Insulin resistance or type 2 diabetes
  • Sedentary lifestyle
  • Family history of type 2 diabetes

Diagnosis

  • Rotterdam criteria (2 of 3: oligo/anovulation, hyperandrogenism, polycystic ovaries on ultrasound)
  • Blood tests for androgens (testosterone, DHEA-S), glucose, insulin, and lipids
  • Pelvic ultrasound showing multiple small follicles (≥12 per ovary or ovarian volume >10 mL)
  • Exclusion of other causes (thyroid disease, congenital adrenal hyperplasia, Cushing syndrome)

Treatment

  • Lifestyle modifications (weight loss of 5–10% significantly improves symptoms)
  • Combined oral contraceptive pills for cycle regulation and androgen reduction
  • Metformin for insulin resistance
  • Spironolactone for hirsutism and acne
  • Letrozole or clomiphene for ovulation induction (fertility treatment)
  • In vitro fertilization (IVF) for resistant infertility

Natural remedies for polycystic ovary syndrome: what the evidence says

Ranked by the strength of human evidence for polycystic ovary syndrome specifically. These sit alongside medical care, not in place of it.

  1. Myo-Inositol

    Strong evidence

    A 2023 meta-analysis of 26 randomised trials found inositol improved menstrual regularity, fasting insulin and HOMA-IR, and lowered total testosterone, with effects comparable to metformin and far fewer gut side effects. In a 12 to 16 week RCT of 4 g/day myo-inositol with folic acid, ovulation was restored in most previously anovulatory women and testosterone fell by about half. Head-to-head work supports a 40:1 myo- to D-chiro-inositol ratio over myo-inositol alone for metabolic outcomes.

    Studied dose
    4 g/day myo-inositol (2 g twice daily), usually combined with D-chiro-inositol at a 40:1 ratio (about 100 mg) and 400 mcg folic acid, for at least 3 months.
    Cautions
    Can add to the glucose-lowering effect of metformin or insulin; mild nausea or loose stools at higher doses. Appears safe in pregnancy and is studied for gestational diabetes, but confirm with your obstetrician.
  2. Berberine

    Moderate evidence

    In a 3-month RCT of 89 women with PCOS and insulin resistance, berberine 500 mg three times daily lowered waist circumference, triglycerides and LDL more than metformin, with comparable improvement in insulin sensitivity. A 150-woman trial before IVF found berberine raised clinical pregnancy rates and reduced BMI. Trials are short and mostly Chinese, so durability is unknown.

    Studied dose
    500 mg two to three times daily with meals, for 3 months, then reassess.
    Cautions
    Inhibits CYP3A4 and CYP2D6, raising levels of cyclosporine, some statins and many other drugs; additive glucose lowering with metformin. Avoid in pregnancy and breastfeeding (neonatal jaundice risk); constipation and cramping are common.
  3. NAC (N-Acetyl Cysteine)

    Moderate evidence

    A 2015 meta-analysis of 8 RCTs (910 women) found NAC increased ovulation and pregnancy rates versus placebo and performed comparably to metformin on those outcomes. In 150 clomiphene-resistant women, adding NAC 1.2 g/day to clomiphene raised the ovulation rate from 1 percent to 49 percent and the pregnancy rate from 0 to 21 percent. A 1.8 g/day trial over 5 to 6 weeks improved insulin sensitivity in those with high insulin.

    Studied dose
    600 mg two to three times daily (1.2 to 1.8 g/day) for 2 to 6 months; 1.2 g/day from cycle day 3 for 5 days when combined with clomiphene.
    Cautions
    Can intensify the headache and blood-pressure drop of nitroglycerin; nausea and a sulphur smell are common. Stop a week before surgery because of a theoretical bleeding effect; safety in pregnancy is not established at these doses.
  4. Omega-3 (EPA/DHA)

    Moderate evidence

    A 2018 meta-analysis of 9 RCTs found omega-3 supplementation in PCOS reduced HOMA-IR, triglycerides, total cholesterol and LDL compared with placebo, over 8 to 24 weeks. Individual trials of 1 to 3 g/day also reported lower CRP and, in some, lower testosterone and more regular cycles, though hormonal effects are inconsistent.

    Studied dose
    1 to 2 g/day combined EPA and DHA from fish or algal oil with food, for at least 8 weeks.
    Cautions
    Adds to the effect of warfarin, DOACs and aspirin; tell your surgeon before a procedure. Choose a purified product if pregnant to limit mercury, and expect fishy burps or loose stools at high doses.
  5. Vitamin D

    Moderate evidence

    Between 67 and 85 percent of women with PCOS have low vitamin D, and deficiency tracks with worse insulin resistance and ovulation. A 2018 meta-analysis of RCTs found supplementation lowered HOMA-IR and triglycerides, with modest reductions in total testosterone in some trials. It is best viewed as correcting a deficit, not treating the syndrome.

    Studied dose
    1,000 to 4,000 IU/day vitamin D3 with a fat-containing meal, or 50,000 IU weekly for 8 to 12 weeks if a blood test shows deficiency, then a maintenance dose.
    Cautions
    High doses can cause hypercalcaemia, especially with thiazide diuretics or calcium supplements; check a 25(OH)D level rather than guessing. Safe in pregnancy at ordinary doses.
  6. Chromium

    Moderate evidence

    A 2017 meta-analysis of 7 RCTs found chromium picolinate (200 to 1,000 mcg/day for 8 weeks to 6 months) reduced BMI, fasting insulin and free testosterone in PCOS. A pilot study of 1,000 mcg/day for 2 months improved glucose disposal by 38 percent. Trials are small and heterogeneous, and one head-to-head found metformin clearly superior for ovulation.

    Studied dose
    200 to 1,000 mcg/day chromium picolinate with food for 8 to 12 weeks.
    Cautions
    May lower blood sugar further with metformin or insulin; rare reports of kidney injury at very high doses. Avoid in known kidney or liver disease and in pregnancy beyond dietary amounts.
  7. Cinnamon

    Preliminary evidence

    In a 6-month RCT of 45 women, cinnamon 1.5 g/day produced more menstrual cycles than placebo (an average of 3.8 versus 2.2 over the study) and some ovulatory cycles confirmed by progesterone. An 8-week pilot of 15 women found improved insulin sensitivity on 1 g/day. These are small studies and the metabolic effect was not seen in every trial.

    Studied dose
    1 to 1.5 g/day of cinnamon powder or extract, ideally Ceylon (Cinnamomum verum) rather than cassia.
    Cautions
    Cassia cinnamon contains coumarin, which can stress the liver at gram doses over months; additive glucose lowering with metformin. Culinary amounts are fine in pregnancy, supplement doses are untested.
  8. Magnesium Glycinate

    Preliminary evidence

    Women with PCOS have lower magnesium status on average, and low magnesium is linked to insulin resistance. Small RCTs of magnesium 250 mg/day for 8 weeks, alone or with zinc, calcium and vitamin D, reported lower CRP and mild improvement in insulin markers, but a single-nutrient trial found no change in HOMA-IR. The evidence is thin and best framed as supporting sleep and insulin signalling rather than treating PCOS.

    Studied dose
    200 to 400 mg elemental magnesium as glycinate in the evening for 8 to 12 weeks.
    Cautions
    Reduce the dose or avoid in kidney disease; separate from quinolone and tetracycline antibiotics by 2 hours. Loose stools signal too much; safe in pregnancy at these doses.

What matters day to day

  • Aim for a 5 percent weight loss if you carry excess weight: in trials this alone restored ovulation in a majority of women and lowered free testosterone, which is why the guideline lists lifestyle change as first-line.
  • Lift weights two to three times a week: resistance training improved insulin sensitivity and androgen levels in PCOS trials even without weight change, because muscle is the main site of glucose disposal.
  • Choose lower-glycaemic carbohydrates (legumes, oats, intact grains) and pair them with protein: a low-GI diet improved insulin sensitivity and cycle regularity more than a conventional healthy diet in a 12-month PCOS trial.
  • Protect sleep and get screened for sleep apnoea if you snore or wake unrefreshed: it is several times more common in PCOS and worsens insulin resistance independently of weight.
  • Ask for a glucose tolerance test rather than a fasting glucose alone every 1 to 3 years: fasting glucose misses most early dysglycaemia in PCOS.

Prevention

  • PCOS itself cannot be prevented, but complications can be reduced by:
  • Maintaining a healthy weight through diet and exercise
  • Monitoring and managing blood sugar and insulin levels
  • Regular screening for diabetes and cardiovascular risk factors

When to See a Doctor

  • Irregular or absent menstrual periods
  • Unwanted facial or body hair growth
  • Difficulty conceiving after 12 months of trying
  • Signs of insulin resistance or rapid weight gain

Frequently Asked Questions

References

  1. Teede HJ, Tay CT, Laven JJE, et al.. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism (2023)
  2. Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocrine Connections (2017)
  3. Greff D, Juhász AE, Váncsa S, et al.. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reproductive Biology and Endocrinology (2023)
  4. Nordio M, Proietti E. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. European Review for Medical and Pharmacological Sciences (2012)
  5. Wei W, Zhao H, Wang A, et al.. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. European Journal of Endocrinology (2012)
  6. Thakker D, Raval A, Patel I, Walia R. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstetrics and Gynecology International (2015)
  7. Yang K, Zeng L, Bao T, Ge J. Effectiveness of omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reproductive Biology and Endocrinology (2018)
  8. Kort DH, Lobo RA. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. American Journal of Obstetrics and Gynecology (2014)
  9. Fazelian S, Rouhani MH, Bank SS, Amani R. Chromium supplementation and polycystic ovary syndrome: a systematic review and meta-analysis. Journal of Trace Elements in Medicine and Biology (2017)
  10. Polycystic ovary syndrome: overview and treatment. NHSView source

Related Conditions

Related from the Supplement Library

These supplements have been studied in relation to Polycystic Ovary Syndrome. Always consult your healthcare provider before starting any supplement, especially if you take medications.

Related Reading

Have questions about Polycystic Ovary Syndrome?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.